搜索临床试验以:Basal Cell carcinoma
总计68569个结果
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)完全的
-
Joint Authority for Päijät-Häme Social and Health...Tampere University; University of Jyvaskyla主动,不招人
-
Anne ChangNational Cancer Institute (NCI); Merck Sharp & Dohme LLC完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology完全的
-
Central Hospital, Nancy, France未知
-
Anne ChangNovartis Pharmaceuticals终止
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)终止
-
Novartis Pharmaceuticals终止
-
University of ArizonaNational Cancer Institute (NCI)完全的
-
Seton Healthcare FamilyUniversity of Texas at Austin; Dell Medical School at The University of Texas at Austin撤销基底细胞癌 (BCC) | 鳞状细胞癌 (SCC)
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); The Emmes Company, LLC完全的
-
Ascend Biopharmaceuticals Ltd完全的
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)完全的
-
Nina BhardwajOncovir, Inc.终止
-
Stanford UniversityNational Cancer Institute (NCI); University Hospitals Cleveland Medical Center完全的
-
Dana-Farber Cancer InstituteCelgene Corporation终止头颈部鳞状细胞癌 | 基底样鳞状细胞癌 | 未分化癌 | 腺鳞癌
-
Norwegian University of Science and TechnologyOslo University Hospital; Helse Stavanger HF; Haukeland University Hospital; Førde Central Hospital 和其他合作者完全的
-
Hoffmann-La Roche完全的
-
Neotherix LimitedNAMSA; Innovate UK; Lorien Engineering Solutions (a division of GP Strategies Ltd); Smith & Nephew...完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Hoffmann-La Roche完全的
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的乳腺癌 | 头颈癌 | 肺癌 | 未明确的成人实体瘤,特定方案 | 膀胱癌
-
Hoffmann-La Roche终止
-
Novartis Pharmaceuticals撤销基底细胞癌希腊, 瑞士, 德国, 英国, 比利时, 加拿大, 捷克语, 芬兰, 意大利, 西班牙